Drug firms agree to settle U.S. suit for $176 million

Article Abstract:

Major pharmaceutical makers have reached an agreement to pay a settlement of $176 million in a case that alleged the firms overcharged consumers in California for drugs, even as they gave discounts to large buyers. These drugs were purchased at small pharmacies. The case is the latest in a continuing legal fight between major drug manufacturers and independent pharamacies and their customers. Customers claim that a dual pricing system dominated the drug industry in the early 1990s.

Comment:

Major pharmaceutical makers to pay a settlement of $176 million US in suit

Legal issues & crime, Abstract

---

U.S. jury deadlocks on Genentech case

Article Abstract:

A human growth hormone patent infringement lawsuit filed by the University of California at San Francisco (UCSF) against South San Francisco, Calif.-based Genentech ended when the US. federal judge dismissed the deadlocked jury. Genentech, which had faced $200 million in damages if convicted, has turned the human growth hormone into a major product. UCSF is considering filing a new suit.

Pharmaceutical Preparation Manufacturing, Biological Product (except Diagnostic) Manufacturing, Biological Products, Hormones NEC, Biological products industry, Genentech Inc., Hormones, University of California (San Francisco)

---

Drug Makers' Fight For Patent Rights Puts Them in a Vise

Article Abstract:

A lawsuit by forty pharmaceutical companies seeks to overturn a law signed by former South African president Nelson Mandela. The lawsuit, which is being heard by a Pretoria court, revolves around a law that allows the importing of generic drugs based on patented drugs.

Government domestic functions, South Africa, Health aspects, Laws, regulations and rules, International aspects, Mandela, Nelson, Africa, AIDS (Disease)

Similar abstracts:

• Abstracts: Pirelli: route to success. Pirelli announces factory closures and job losses. Pirelli's net profit increased by 4.3% to $297 million in '98
• Abstracts: Agrofert saw a profit of CEK 399 mil in 2000. Spolchemie co-operates with Eka Chemicals. Synthesia to dismiss 940 employees
• Abstracts: The number of payments in shops doubles. Cash cards still on the rise. There are mainly EC/MC cards in the Czech Republic
• Abstracts: Available output. Demand for electric power in the Czech Republic
• Abstracts: War clouds over Pakistan. APEC backs U.S. in war, but disagrees with tactics. Bush should be less romantic about one Korea...

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.